Denosumab Is Superior to Raloxifene in Lowering Risks of Mortality and Ischemic Stroke in Osteoporotic Women

Both osteoporosis and cardiovascular disease (CVD) share similar pathways in pathophysiology and are intercorrelated with increased morbidity and mortality in elderly women. Although denosumab and raloxifene are the current guideline-based pharmacological treatments, their impacts on cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ting-Chun, Hsu, Chien-Ning, Lee, Wen-Chin, Wang, Shih-Wei, Huang, Chiang-Chi, Lee, Yueh-Ting, Fu, Chung-Ming, Chen, Jin-Bor, Li, Lung-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966982/
https://www.ncbi.nlm.nih.gov/pubmed/37259371
http://dx.doi.org/10.3390/ph16020222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966982/
https://www.ncbi.nlm.nih.gov/pubmed/37259371
http://dx.doi.org/10.3390/ph16020222

Ejemplares similares